Cationic niosome-based hBMP7 gene transfection of neuronal precursor NT2 cells to reduce the migration of glioma cells in vitro
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
NTERA2 cells are capable of differentiating into glia and neurons.
“NTERA2 teratocarcinoma cells closely resemble neural stem/progenitor cells, as they are capable of differentiating into glia and neurons, and of locating and targeting glioma neoplasms in mouse models, particularly following treatment with retinoic acid [45,46,47,48].”
From Optimized Wound Healing Assay to Study Extracellular Vesicle-Driven Glioblastoma Cell Migration (2026) · cites this paper as [47]
Glioblastoma cells are responsive to signals emitted by NTERA2 cells.
“suggesting that GB cells are responsive to signals emitted by NTERA2 cells.”
From Optimized Wound Healing Assay to Study Extracellular Vesicle-Driven Glioblastoma Cell Migration (2026) · cites this paper as [47]
NTERA2 teratocarcinoma cells closely resemble neural stem/progenitor cells.
“NTERA2 teratocarcinoma cells closely resemble neural stem/progenitor cells, as they are capable of differentiating into glia and neurons, and of locating and targeting glioma neoplasms in mouse models, particularly following treatment with retinoic acid [45,46,47,48].”
From Optimized Wound Healing Assay to Study Extracellular Vesicle-Driven Glioblastoma Cell Migration (2026) · cites this paper as [47]
NTERA2 cells can locate and target glioma neoplasms in mouse models, particularly following retinoic acid treatment.
“NTERA2 teratocarcinoma cells closely resemble neural stem/progenitor cells, as they are capable of differentiating into glia and neurons, and of locating and targeting glioma neoplasms in mouse models, particularly following treatment with retinoic acid [45,46,47,48].”
From Optimized Wound Healing Assay to Study Extracellular Vesicle-Driven Glioblastoma Cell Migration (2026) · cites this paper as [47]
Conditioned medium from NTERA2 cells affects glioblastoma cell behavior.
“it has been found that conditioned medium from NTERA2 cells affects GB cell behavior [47]”
From Optimized Wound Healing Assay to Study Extracellular Vesicle-Driven Glioblastoma Cell Migration (2026) · cites this paper as [47]
Cites
Differentiated Rat Glial Cell Strain in Tissue Culture
Benda, P., Lightbody, J., SATO, G. H., Levine, L., & Sweet, W. H. (1968) · Science · doi:10.1126/science.161.3839.370 · Cited by 1,472 · see citing works
Giannini, C., Sarkaria, J. N., Saito, A., Uhm, J. H., Galanis, E., Carlson, B. L., Schroeder, M. A., & James, C. D. (2005) · Neuro-Oncology · doi:10.1215/s1152851704000821 · Cited by 326 · see citing works
Biophysical characterization of cationic lipid:DNA complexes
Eastman, S. J., Siegel, C., Tousignant, J. D., Smith, A. E., Cheng, S. H., & Scheule, R. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(96)00242-8 · Cited by 271 · see citing works
A novel cationic niosome formulation for gene delivery to the retina
Puras, G., Mashal, M., Zárate, J., Agirre, M., Ojeda, E., Grijalvo, S., Eritja, R., Diaz-Tahoces, A., Martínez Navarrete, G., Avilés-Trigueros, M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.004 · Cited by 164 · see citing works
Self-citationChirasani, S. R., Sternjak, A., Wend, P., Momma, S., Campos, B., Herrmann, I. M., Graf, D., Mitsiadis, T. A., Herold‐Mende, C. C., Besser, D., et al. (2010) · Brain · doi:10.1093/brain/awq128 · Cited by 95 · see citing works
Grijalvo, S., Puras, G., Sesma, J. Z., Sainz-Ramos, M., Qtaish, N. A., López-Méndez, T. B., Mashal, M., Attia, N., Díaz, D. D., Pons, R., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020050 · Cited by 95 · see citing works
Self-citationThe use of neural stem cells in cancer gene therapy: predicting the path to the clinic.
Ahmed, A. U., Alexiades, N. G., & Lesniak, M. S. (2010) · PubMed · Cited by 83 · see citing works
Mashal, M., Attia, N., Puras, G., Martínez-Navarrete, G., Fernández, E., & Pedraz, J. L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.386 · Cited by 74 · see citing works
Self-citationSnail depletes the tumorigenic potential of glioblastoma
Savary, K., Çağlayan, D., Caja, L., Tzavlaki, K., Nayeem, S. B., Bergström, T., Jiang, Y., Uhrbom, L., Forsberg‐Nilsson, K., Westermark, B., et al. (2013) · Oncogene · doi:10.1038/onc.2013.67 · Cited by 67 · see citing works
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells
Tate, C. M., D, R. P. M., Ricci‐Vitiani, L., Dowless, M. S., Shiyanova, T. L., D’Alessandris, Q. G., Morgante, L., Giannetti, S., Larocca, L. M., Martino, S. D., et al. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.44 · Cited by 67 · see citing works
Mashal, M., Attia, N., Martínez-Navarrete, G., Soto-Sánchez, C., Fernández, E., Grijalvo, S., Eritja, R., Puras, G., & Pedraz, J. L. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.010 · Cited by 58 · see citing works
Self-citationStem cells as therapeutic vehicles for the treatment of high-grade gliomas
Binello, E., & Germano, I. M. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor204 · Cited by 57 · see citing works
Ojeda, E., Puras, G., Agirre, M., Sesma, J. Z., Grijalvo, S., Pons, R., Eritja, R., Martı́nez, G., Soto‐Sánchez, C., Fernández, E., et al. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob02087a · Cited by 56 · see citing works
Self-citationStem cell-based gene delivery mediated by cationic niosomes for bone regeneration
Attia, N., Mashal, M., Grijalvo, S., Eritja, R., Sesma, J. Z., Puras, G., & Pedraz, J. L. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.11.005 · Cited by 52 · see citing works
Self-citationTransforming growth factor β and bone morphogenetic protein actions in brain tumors
Caja, L., Bellomo, C., & Moustakas, A. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.058 · Cited by 47 · see citing works
Tso, J. L., Yang, S., Menjivar, J. C., Yamada, K., Zhang, Y., Hong, I., Bui, Y., Stream, A., McBride, W. H., Liau, L. M., et al. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0459-1 · Cited by 47 · see citing works
Timmerman, P., Jolliffe, K. A., Calama, M. C., Weidmann, J.-L., Prins, L. J., Cardullo, F., Snellink‐Ruël, B. H. M., Fokkens, R. H., Nibbering, N. M. M., Shinkai, S., et al. (2000) · Chemistry - A European Journal · doi:10.1002/1521-3765(20001117)6:22 · Cited by 44 · see citing works
Tsai, M., Weng, C., Shyue, S., Liou, D.-Y., Chen, C., Chiu, C.-W., Yang, T., Pan, H., Liao, R. I., Kuo, H., et al. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21395 · Cited by 39 · see citing works
Mashal, M., Attia, N., Soto‐Sánchez, C., Martı́nez, G., Fernández, E., Puras, G., & Pedraz, J. L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.038 · Cited by 36 · see citing works
Self-citationNana, A. W., Yang, P.-M., & Lin, H. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.16.6813 · Cited by 33 · see citing works
Cacciotti, I., Ceci, C., Bianco, A., & Pistritto, G. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.07.033 · Cited by 27 · see citing works
Caricasole, A., Oostwaard, D. W., Zeinstra, L. M., Raaij, A. V. D. E., & Mummery, C. L. (2000) · The International Journal of Developmental Biology · doi:10.1387/ijdb.11032177 · Cited by 25 · see citing works
Guan, Y., Chen, J., Zhan, Y., & Lu, H. (2018) · Oncology Letters · doi:10.3892/ol.2018.8269 · Cited by 22 · see citing works
Ojeda, E., Agirre, M., Villate-Beitia, I., Mashal, M., Puras, G., Sesma, J. Z., & Pedraz, J. L. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3718-9_5 · Cited by 21 · see citing works
Self-citationAttia, N., Santos‐Vizcaíno, E., Abdelmouty, H., Arafa, S. A., Zohdy, N., Hernández, R. M., Orive, G., & Pedraz, J. L. (2014) · Journal of Microencapsulation · doi:10.3109/02652048.2014.898706 · Cited by 19 · see citing works
Self-citationAttia, N., Mashal, M., Soto‐Sánchez, C., Martı́nez, G., Fernández, E., Grijalvo, S., Eritja, R., Puras, G., & Pedraz, J. L. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s178532 · Cited by 15 · see citing works
Self-citationHess, D. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-15063-5 · Cited by 12 · see citing works
Development of BMP7-producing human cells, using a third generation lentiviral gene delivery system
Chitty, D. W., Tremblay, R. G., Ribecco‐Lutkiewicz, M., Haukenfrers, J., Zurakowski, B., Bernard Massie, B., Sikorska, M., & Bani‐Yaghoub, M. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.12.007 · Cited by 9 · see citing works
Neural Stem Cells in Stroke: Intracerebral Approaches
Manley, N. C., Azevedo-Pereira, R. L., Bliss, T. M., & Steinberg, G. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-15063-5_7 · Cited by 7 · see citing works
Non-Viral Gene Delivery Vectors
(2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3718-9 · Cited by 7 · see citing works
Law, S. L., Chuang, T., Kao, M., Lin, Y.-S., & Huang, K.-J. (2006) · Drug Delivery · doi:10.1080/10717540500309024 · Cited by 6 · see citing works
Conditioned medium from neural stem cells inhibits glioma cell growth.
Li, Z., Zhong, Q., Liu, H., Liu, P., Wu, J., Ma, D.-N., Chen, X., & Yang, X. (2016) · PubMed · doi:10.14715/cmb/2016.62.12.12 · Cited by 3 · see citing works
The role of bone morphogenetic protein 2 in ovarian cancer migration
Lau, K. S.-K. (2016) · cIRcle (University of British Columbia) · doi:10.14288/1.0307514 · Cited by 1 · see citing works
Flagged first, then by citations
3 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Akbarzadeh, I., Yaraki, M. T., Bourbour, M., Noorbazargan, H., Lajevardi, A., Shilsar, S. M. S., Heidari, F., & Mousavian, S. M. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101715 · Cited by 86 · see citing works
AL Qtaish, N., Gallego, I., Villate-Beitia, I., Sainz-Ramos, M., López-Méndez, T. B., Grijalvo, S., Eritja, R., Soto-Sánchez, C., Martínez-Navarrete, G., Fernández, E., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030198 · Cited by 57 · see citing works
Self-citationMesenchymal Stem Cells as a Gene Delivery Tool: Promise, Problems, and Prospects
Attia, N., Mashal, M., Puras, G., & Pedraz, J. L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060843 · Cited by 38 · see citing works
Self-citationPoustforoosh, A. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.125338 · Cited by 28 · see citing works
Poustforoosh, A. (2024) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2024.133547 · Cited by 28 · see citing works
Habeeb, M., Vengateswaran, H. T., You, H. W., Saddhono, K., Aher, K. B., & Bhavar, G. B. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02485g · Cited by 27 · see citing works
Challenges and Promise for Glioblastoma Treatment through Extracellular Vesicle Inquiry
Liguori, G. L. (2024) · Cells · doi:10.3390/cells13040336 · Cited by 24 · see citing works
Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies
Attia, N., Mashal, M., Pemminati, S., Omole, A. E., Edmondson, C. K., Jones, W., Priyadarshini, P., Mughal, T., Aziz, P., Zenick, B., et al. (2021) · Cells · doi:10.3390/cells11010116 · Cited by 23 · see citing works
Self-citationLiguori, G. L., & Kralj‐Iglič, V. (2023) · Cancers · doi:10.3390/cancers15184425 · Cited by 20 · see citing works
Mashal, M., Attia, N., Grijalvo, S., Eritja, R., Puras, G., & Pedraz, J. L. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2219420 · Cited by 19 · see citing works
Self-citationMantile, F., Kisovec, M., Adamo, G., Romancino, D. P., Hočevar, M., Božič, D., Bedina Zavec, A., Podobnik, M., Stoppelli, M. P., Kisslinger, A., et al. (2022) · Cancers · doi:10.3390/cancers14153700 · Cited by 18 · see citing works
Mashal, M., Attia, N., Maldonado, I., Enríquez, L., Gallego, I., Puras, G., & Pedraz, J. L. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114385 · Cited by 7 · see citing works
Self-citationAttia, N., Khalifa, Y. H., Mashal, M., Puras, G., & Pedraz, J. L. (2022) · Advances in experimental medicine and biology · doi:10.1007/5584_2022_754 · Cited by 3 · see citing works
Self-citationExtracellular Vesicles: The Challenges on the Way and Engineering Perspectives
Attia, N., Ibrahim, H. G., Abdulla, H., Mashal, M., Puras, G., & Pedraz, J. L. (2024) · Springer eBooks · doi:10.1007/978-981-99-7119-0_56 · Cited by 1 · see citing works
Self-citationOptimized Wound Healing Assay to Study Extracellular Vesicle-Driven Glioblastoma Cell Migration
D’Antonio, C., Mantile, F., Pocsfalvi, G., & Liguori, G. L. (2026) · Methods and Protocols · doi:10.3390/mps9030081
“Furthermore, it has been found that conditioned medium from NTERA2 cells affects GB cell behavior [47], suggesting that GB cells are responsive to signals emitted by NTERA2 cells.”
Viral and Nonviral Drug Delivery Systems for Medical Health Care: An Overview
Ghosh, A., Gouda, S., Kerry, R. G., Das, G., & Patra, J. K. (2020) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-39246-8_2
Extracellular Vesicles: The Challenges on the Way and Engineering Perspectives
Attia, N., Ibrahim, H. G., Abdulla, H., Mashal, M., Puras, G., & Pedraz, J. L. (2023) · Springer eBooks · doi:10.1007/978-981-99-0846-2_56-1
Self-citation
- Authors
- Attia, N., Mashal, M., Grijalvo, S., Eritja, R., Puras, G., & Pedraz, J. L.
- Affiliations
- University of the Basque Country (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Corresponding author
- Puras, Gustavo
- Venue
- Journal of Drug Delivery Science and Technology
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 53
- Pages
- 101219
- ISSN
- 1773-2247 (ISSN-L)
- OpenAlex
- W2968460843
- Cited by
- 17
- References
- 36
- Citations by year
- 2026: 1 · 2024: 6 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 3
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Drug Delivery Science and Technology (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Funders
- Instituto de Salud Carlos III (CB06_01_0019, CB06_01_1028)
- Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina
- Center for International Business Education and Research, University of Illinois at Urbana-Champaign
- Generalitat de Catalunya (2014/SGR/624)
- Euskal Herriko Unibertsitatea
- Ministerio de Educación, Cultura y Deporte (CTQ2014-52588-R)
- Topics
- Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- bone morphogenetic protein-7, transfection, glioblastoma, glioma cell migration, C6 glioma cells, non-viral gene delivery, anticancer activity, metastasis suppression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
